Evaluation of Devices Used with Regenerative Medicine Advanced Therapies: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 15, 2019
July 29, 2019
0bd9718e-c6aa-4925-902b-f84e80a50ef9
Related Documents
Content of Premarket Submissions for Device Software Functions: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentJune 14, 2023Center for Devices and Radiological Health
Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry
Guidance DocumentOctober 16, 2020Center for Biologics Evaluation and Research
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentJuly 20, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox